NCT05763277
- Conditions
- Adenocarcinoma, Atezolizumab-bevacizumab, Carcinoma, +11 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
Clinical trial condition
Response Evaluation
Explore clinical trials studying Response Evaluation. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study